Cargando…
New frontiers in liver resection for hepatocellular carcinoma
Liver resection is one of the main curative options for early hepatocellular carcinoma (HCC) in patients with cirrhosis and is the treatment of choice in non-cirrhotic patients. However, careful patient selection is required to balance the risk of postoperative liver failure and the potential benefi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360891/ https://www.ncbi.nlm.nih.gov/pubmed/32695968 http://dx.doi.org/10.1016/j.jhepr.2020.100134 |
_version_ | 1783559302978469888 |
---|---|
author | Allaire, Manon Goumard, Claire Lim, Chetana Le Cleach, Aline Wagner, Mathilde Scatton, Olivier |
author_facet | Allaire, Manon Goumard, Claire Lim, Chetana Le Cleach, Aline Wagner, Mathilde Scatton, Olivier |
author_sort | Allaire, Manon |
collection | PubMed |
description | Liver resection is one of the main curative options for early hepatocellular carcinoma (HCC) in patients with cirrhosis and is the treatment of choice in non-cirrhotic patients. However, careful patient selection is required to balance the risk of postoperative liver failure and the potential benefit on long-term outcomes. In the last decades, improved surgical techniques and perioperative management, as well as better patient selection, have enabled the indications for liver resection to be expanded. In this review, we aim to describe the main indications for liver resection in the management of HCC, its role compared to percutaneous ablation and liver transplantation in the therapeutic algorithm, as well as the recent advances in liver surgery that could be used to improve the prognosis of patients with HCC. |
format | Online Article Text |
id | pubmed-7360891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-73608912020-07-20 New frontiers in liver resection for hepatocellular carcinoma Allaire, Manon Goumard, Claire Lim, Chetana Le Cleach, Aline Wagner, Mathilde Scatton, Olivier JHEP Rep Review Liver resection is one of the main curative options for early hepatocellular carcinoma (HCC) in patients with cirrhosis and is the treatment of choice in non-cirrhotic patients. However, careful patient selection is required to balance the risk of postoperative liver failure and the potential benefit on long-term outcomes. In the last decades, improved surgical techniques and perioperative management, as well as better patient selection, have enabled the indications for liver resection to be expanded. In this review, we aim to describe the main indications for liver resection in the management of HCC, its role compared to percutaneous ablation and liver transplantation in the therapeutic algorithm, as well as the recent advances in liver surgery that could be used to improve the prognosis of patients with HCC. Elsevier 2020-06-04 /pmc/articles/PMC7360891/ /pubmed/32695968 http://dx.doi.org/10.1016/j.jhepr.2020.100134 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Allaire, Manon Goumard, Claire Lim, Chetana Le Cleach, Aline Wagner, Mathilde Scatton, Olivier New frontiers in liver resection for hepatocellular carcinoma |
title | New frontiers in liver resection for hepatocellular carcinoma |
title_full | New frontiers in liver resection for hepatocellular carcinoma |
title_fullStr | New frontiers in liver resection for hepatocellular carcinoma |
title_full_unstemmed | New frontiers in liver resection for hepatocellular carcinoma |
title_short | New frontiers in liver resection for hepatocellular carcinoma |
title_sort | new frontiers in liver resection for hepatocellular carcinoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360891/ https://www.ncbi.nlm.nih.gov/pubmed/32695968 http://dx.doi.org/10.1016/j.jhepr.2020.100134 |
work_keys_str_mv | AT allairemanon newfrontiersinliverresectionforhepatocellularcarcinoma AT goumardclaire newfrontiersinliverresectionforhepatocellularcarcinoma AT limchetana newfrontiersinliverresectionforhepatocellularcarcinoma AT lecleachaline newfrontiersinliverresectionforhepatocellularcarcinoma AT wagnermathilde newfrontiersinliverresectionforhepatocellularcarcinoma AT scattonolivier newfrontiersinliverresectionforhepatocellularcarcinoma |